Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity

CONTEXT: Prader–Willi syndrome (PWS) is characterized by lack of appetite control and hyperphagia, leading to obesity. Pharmacological options for weight management are needed. OBJECTIVE: To determine whether liraglutide treatment for weight management is superior to placebo/no treatment in pediatri...

Descripción completa

Detalles Bibliográficos
Autores principales: Diene, Gwenaëlle, Angulo, Moris, Hale, Paula M, Jepsen, Cecilie H, Hofman, Paul L, Hokken-Koelega, Anita, Ramesh, Chethana, Turan, Serap, Tauber, Maïthé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759167/
https://www.ncbi.nlm.nih.gov/pubmed/36181471
http://dx.doi.org/10.1210/clinem/dgac549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759167/
https://www.ncbi.nlm.nih.gov/pubmed/36181471
http://dx.doi.org/10.1210/clinem/dgac549

Ejemplares similares